Sinopharm Tech (08156): Yu Bingming is elected as an independent non-executive director.

SINOPHARM TECH (08156) announced that after the shareholder's annual meeting, Dr. Cheng Yanjie (Dr. Cheng) has stepped down as a non-executive director of the company. Mr. Diao Zhiqiang (Mr. Diao) and Mr. Yu Bingming (Mr. Yu) have both been elected by the company's shareholders at the annual meeting to serve as independent non-executive directors of the company. The board of directors further announced that Mr. Xu Dong'an (Mr. Xu) has resigned as an independent non-executive director of the company due to other business commitments, effective from December 19, 2025 (after the shareholder's annual meeting). The board of directors also announced changes to the composition of the board committees, all of which are effective from December 19, 2025 (after the shareholder's annual meeting): (1) Mr. Xu has resigned as chairman of the nomination committee and as a member of the audit committee, compensation committee, and nomination committee; (2) Ms. Guo Shuyi has been appointed as a member of the compensation committee and nomination committee; (3) Mr. Liu Fei has been appointed as a member and chairman of the nomination committee; (4) Mr. Diao has been appointed as a member of the audit committee, compensation committee, and nomination committee; and (5) Mr. Yu has been appointed as a member of the audit committee, compensation committee, and nomination committee.